Reality Bites: Disappointment in the R&D Sector
Pharmaceutical Technology
JULY 10, 2008
“To remain at the forefront of medical research, pharma needs a faster, more predictive way of testing molecules before they go into humans,” says Steve Arlington, global life sciences industry advisor leader at PwC. %, while R&D accounts for just 17.1% “It’s very disappointing.
52 
Let's personalize your content